Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial.

Authors
  • 1
  • 1 INSERM UMR-S850, Limoges, France. , (France)
Type
Published Article
Journal
Transplantation
1534-6080
Publication Date
Volume
89
Issue
10
Pages
1255–1262
Identifiers
DOI: 10.1097/TP.0b013e3181d75952
PMID: 20224514
Source
Medline
License
Unknown

Abstract

In the APOMYGRE trial, therapeutic MPA monitoring using a limited sampling strategy reduced the risk of treatment failure and acute rejection in renal allograft recipients during the first 12 months posttransplantation, at neutral cost.

Statistics

Seen <100 times